AIM IMMUNOTECH INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend
AIM IMMUNOTECH INC. (AIM) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend of $0 for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend · last filed 2018-11-14
- AIM IMMUNOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average expected dividend for the quarter ending 2018-03-31 was $0.00.
- AIM IMMUNOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average expected dividend for the quarter ending 2017-03-31 was $0.00.
- AIM IMMUNOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average expected dividend for fiscal 2017 was $0.00.
- AIM IMMUNOTECH INC. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average expected dividend for fiscal 2016 was $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-14 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-14 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 | |||
| 2017-12-31 | $0.00 10-K · filed 2018-03-30 | |||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-14 | |||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | |||
| 2016-12-31 | $0.00 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |